FT Global Pharmaceutical and Biotechnology Conference
6 August 2013 | By Financial Times
3 – 4 December 2013, The InterContinental Park Lane, London...
List view / Grid view
6 August 2013 | By Financial Times
3 – 4 December 2013, The InterContinental Park Lane, London...
5 August 2013 | By Roche
The Medicines Patent Pool and Roche announce an agreement...
24 July 2013 | By Roche
Results from the phase III CLL11 study...
22 July 2013 | By Roche
Roche invites 100 students from all over Europe to the Salzburg Festival...
19 July 2013 | By Roche
Tests support long-term routine management of organ transplant recipients...
18 July 2013 | By Roche
Roche announced the global launch of Elecsys ProGRP...
15 July 2013 | By Roche
The European Commission has granted conditional approval to Erivedge...
10 July 2013 | By Roche
"The safety of patients is our first priority..."
3 July 2013 | By Roche
FDA decision on the GA101 BLA is expected by the end of 2013...
2 July 2013 | By Roche
The U.S. FDA has accepted the company’s sBLA for the use of a Perjeta®...
2 July 2013 | By Roche
Strengthening Roche's commitment to hematology testing...
28 June 2013 | By Roche
"Over the last 14 years, Herceptin has revolutionised the treatment of HER2-positive breast cancer..."
17 June 2013 | By Roche
First approval of Avastin for the treatment of newly diagnosed glioblastoma...
13 June 2013 | By Roche
Roche announced data from two phase III studies...
10 June 2013 | By Roche
“This approval comes earlier than expected, just one month following the positive CHMP opinion...”